FDA Approves Lenvatinib for Advanced Renal Cell CarcinomaFDA Approves Lenvatinib for Advanced Renal Cell Carcinoma

The drug is to be used in combination with everolimus, and improves progression-free survival, overall response rate, and overall survival compared with everolimus alone. FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news